AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
IND Edition 
⚠
✓
Apyx Medical Inc (NASDAQ:APYX)
3.79 USD
-0.060 1.558%Sponsored Reports
Loading...
| Previous Close (in USD) | 3.85 |
|---|---|
| Change | -0.060 1.558% |
| 52 W H/L (in USD) | 4.500/0.825 |
| EBITDA (in USD) | -5.791M |
| PE Ratio | -- |
| Volume | 78917 |
| Diluted Eps TTM | -0.27 |
| Total Assets (in USD) | 66.84M |
|---|---|
| Total Liabilities (in USD) | 52.009M |
| Revenue TTM (in USD) | 52.844M |
| Cash (in USD) | 31.74M |
| Market Cap (in USD) | 163.134 M |
| Revenue Per Share TTM | 1.286 |
| Gross Profit TTM (in USD) | 33.044M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Apyx Medical Inc
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Employees: 205
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Charles D. Goodwin II | Pres, CEO & Director | 1966 |
| 2. | Ms. Tara H. Semb | CFO, Treasurer & Sec. | 1970 |
| 3. | Mr. Moshe Citronowicz | Sr. VP | 1953 |
| 4. | Mr. Todd Hornsby | Exec. VP | 1976 |
| 5. | Mr. Charles D. Goodwin II | President, CEO & Director | 1967 |
| 6. | Mr. Matthew C. Hill CPA | CFO, Treasurer & Secretary | 1969 |
| 7. | Mr. Moshe Citronowicz | Senior Vice President | 1953 |
| 8. | Mr. Todd Hornsby | Executive Vice President | 1977 |
| 9. | Mr. Shawn D. Roman | Chief Operating Officer | 1972 |
| 10. | Ms. Dolores Catania | Chief of Confidence | NA |
Peers
Sector: Healthcare
Industry: Medical Devices
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ABT
Abbott Laboratories |
+0.020 0.023% | 87.195 | 25.970 | 17.241 | 3.570 | 3.200 | 3.805 | 16.753 |
|
SYK
Stryker Corporation |
+1.700 0.580% | 295 | 44.070 | 24.938 | 5.509 | 6.118 | 6.050 | 25.731 |
|
MDT
Medtronic PLC |
+4.200 5.695% | 77.12 | 26.600 | 15.873 | 3.354 | 2.083 | 3.897 | 14.117 |
|
BSX
Boston Scientific Corp |
+0.010 0.021% | 47.81 | 31.490 | 17.241 | 4.407 | 3.650 | 4.878 | 19.194 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
|---|---|---|---|---|---|
| Income Before Tax | -10.835M | -23.307M | -21.282M | -22.911M | -14.82M |
| Minority Interest | -0.106M | 0.096M | 0.136M | -0.094M | -0.028M |
| Net Income | -11.211M | -23.463M | -18.713M | -23.278M | -15.2M |
| Selling General Administrative | 36.117M | 43.125M | 48.866M | 48.149M | 43.728M |
| Gross Profit | 19.033M | 29.36M | 33.759M | 29.131M | 33.601M |
| Reconciled Depreciation | 0.655M | 0.599M | 0.742M | 0.89M | 0.903M |
| Ebit | -6.446M | -17.4M | -18.804M | -23.562M | -14.448M |
| Ebitda | -5.791M | -16.801M | -18.112M | -22.896M | -14.81M |
| Depreciation And Amortization | 0.655M | 0.599M | 0.692M | 0.666M | -0.362M |
| Operating Income | -6.446M | -18.845M | -17.259M | -23.562M | -14.448M |
| Other Operating Expenses | 59.29M | 66.947M | 69.608M | 68.072M | 62.965M |
| Interest Expense | 5.589M | 5.907M | 2.478M | 0.015M | 0.01M |
| Tax Provision | 0.27M | 0.252M | -2.368M | 0.367M | 0.38M |
| Interest Income | 1.108M | 1.606M | 0.542M | 0.157M | 0.011M |
| Net Interest Income | -4.481M | -4.301M | -0.823M | 0.142M | 0.001M |
| Income Tax Expense | 0.27M | 0.252M | -2.432M | 0.367M | 0.38M |
| Total Revenue | 52.844M | 48.102M | 52.349M | 44.51M | 48.517M |
| Total Operating Expenses | 25.479M | 48.205M | 51.018M | 52.693M | 48.049M |
| Cost Of Revenue | 33.811M | 18.742M | 18.59M | 15.379M | 14.916M |
| Total Other Income Expense Net | -4.389M | -4.462M | -4.023M | 0.651M | -0.372M |
| Net Income From Continuing Ops | -11.105M | -23.559M | -15.291M | -23.278M | -15.2M |
| Net Income Applicable To Common Shares | - | - | - | -23.184M | -15.172M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
|---|---|---|---|---|---|
| Total Assets | 66.84M | 64.842M | 79.24M | 51.775M | 68.721M |
| Intangible Assets | - | - | - | - | - |
| Other Current Assets | 1.353M | 1.655M | 2.734M | 2.737M | 1.926M |
| Total Liab | 52.009M | 50.507M | 52.318M | 13.982M | 14.712M |
| Total Stockholder Equity | 14.54M | 14.21M | 26.701M | 37.582M | 53.704M |
| Other Current Liab | 8.214M | 7.058M | 9.173M | 8.075M | 1.863M |
| Common Stock | 0.042M | 0.038M | 0.035M | 0.035M | 0.034M |
| Capital Stock | 0.042M | 0.038M | 0.035M | 0.035M | 0.034M |
| Retained Earnings | -89.122M | -77.911M | -54.448M | -35.735M | -12.551M |
| Good Will | - | - | - | - | - |
| Other Assets | - | - | - | 1.217M | 1.11M |
| Cash | 31.74M | 31.741M | 43.652M | 10.192M | 30.87M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 11.7M | 10.721M | 12.74M | 11.85M | 13.205M |
| Current Deferred Revenue | - | 0.693M | 0.488M | 0.853M | 8.424M |
| Net Debt | 7.6M | 7.023M | -5.151M | -9.396M | -30.565M |
| Short Term Debt | 0.428M | 0.355M | 0.367M | 0.253M | 0.287M |
| Short Long Term Debt | - | - | - | - | - |
| Short Long Term Debt Total | 39.34M | 38.764M | 38.501M | 0.796M | 0.305M |
| Other Stockholder Equity | 103.62M | 92.083M | 81.114M | 73.282M | 66.221M |
| Property Plant Equipment | - | - | - | 6.761M | 6.575M |
| Total Current Assets | 58.471M | 56.44M | 70.362M | 42.972M | 60.737M |
| Long Term Investments | - | - | - | - | - |
| Short Term Investments | - | - | - | - | - |
| Net Receivables | 16.776M | 15.48M | 14.053M | 18.246M | 21.163M |
| Long Term Debt | 34.849M | 33.893M | 33.185M | - | - |
| Inventory | 8.602M | 7.564M | 9.923M | 11.797M | 6.778M |
| Accounts Payable | 3.058M | 2.615M | 2.712M | 2.669M | 2.631M |
| Accumulated Other Comprehensive Income | - | - | 0M | - | - |
| Non Currrent Assets Other | 1.752M | 1.664M | 1.732M | 1.217M | 1.11M |
| Non Current Assets Total | 8.369M | 8.402M | 8.878M | 8.803M | 7.984M |
| Capital Lease Obligations | 4.491M | 4.871M | 5.316M | 0.796M | 0.305M |
| Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
|---|---|---|---|---|---|
| Investments | - | -0.722M | 6.685M | -1.01M | -0.723M |
| Total Cashflows From Investing Activities | -1.114M | -0.722M | 6.734M | -1.01M | -0.723M |
| Total Cash From Financing Activities | 9.58M | 6.745M | 32.166M | 0.217M | 0.024M |
| Net Income | -11.105M | -23.559M | -18.85M | -23.278M | -15.2M |
| Change In Cash | -0.001M | -11.911M | 33.46M | -20.678M | -11.045M |
| Begin Period Cash Flow | 31.741M | 43.652M | 10.192M | 30.87M | 41.915M |
| End Period Cash Flow | 31.74M | 31.741M | 43.652M | 10.192M | 30.87M |
| Total Cash From Operating Activities | -8.001M | -18.047M | -5.249M | -20.28M | -10.449M |
| Depreciation | 0.655M | 0.599M | 0.692M | 0.89M | 0.903M |
| Other Cashflows From Investing Activities | - | - | -0.147M | - | - |
| Dividends Paid | - | - | - | - | - |
| Change To Inventory | -1.074M | 2.263M | 1.459M | -5.568M | -2.859M |
| Sale Purchase Of Stock | - | - | - | - | 0.195M |
| Other Cashflows From Financing Activities | 0.06M | -0.235M | -5.591M | 0.365M | 0.262M |
| Capital Expenditures | 1.114M | 0.722M | 0.533M | 1.01M | 0.723M |
| Change In Working Capital | -1.591M | -1.245M | 5.543M | -5.217M | -1.843M |
| Other Non Cash Items | 2.039M | 2.145M | 2.252M | 0.628M | 0.603M |
| Free Cash Flow | -9.115M | -18.769M | -5.782M | -21.29M | -11.172M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Vanguard Total Stock Mkt Idx Inv | 2 months ago | 1095524 |
| 2. | Royce Micro-Cap Trust | 2 months ago | 663269 |
| 3. | RENN Fund ord | 5 months ago | 615000 |
| 4. | Royce Small-Cap Opportunity Invmt | 2 months ago | 589063 |
| 5. | Royce Micro-Cap Invmt | 2 months ago | 586780 |
| 6. | FTGF RY US SmCp Opp A USD Dis(A) | 2 months ago | 527327 |
| 7. | Vanguard Institutional Extnd Mkt Idx Tr | 2 months ago | 420076 |
| 8. | IMC US Ultra Micro Cap | 2 months ago | 300162 |
| 9. | Royce Capital Micro-Cap Inv | 2 months ago | 215125 |
| 10. | Fidelity Extended Market Index | 3 months ago | 170136 |
| 11. | Pleiades Small Cap Equity A | 5 months ago | 150081 |
| 12. | 1290 Essex Small Cap Growth I | 3 months ago | 146756 |
| 13. | Taylor Frigon Core Growth | 6 months ago | 128436 |
| 14. | iShares Micro-Cap ETF | 2 months ago | 90158 |
| 15. | SEI Small Cap II A (SIIT) | 2 months ago | 79900 |
| 16. | Extended Equity Market Fund E | 5 months ago | 70393 |
| 17. | Blackrock Extended Mkt Fund CF | 3 months ago | 70393 |
| 18. | Extended Equity Market Fund B | 5 months ago | 70393 |
| 19. | Extended Equity Market Fund K | 2 months ago | 59937 |
| 20. | Fidelity Total Market Index | 3 months ago | 56118 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Nantahala Capital Management, LLC | 5 months ago | 3974091 |
| 2. | Archon Capital Management LLC | 5 months ago | 3213226 |
| 3. | Royce & Associates, LP | 5 months ago | 2443035 |
| 4. | Vanguard Group Inc | 5 months ago | 1565078 |
| 5. | AIGH Capital Management, LLC | 5 months ago | 1104970 |
| 6. | Silverberg Bernstein Capital Management LLC | 2 months ago | 1041070 |
| 7. | Commonwealth Equity Services Inc | 5 months ago | 663541 |
| 8. | Horizon Asset Management Inc/ny | 5 months ago | 615000 |
| 9. | BlackRock Inc | 8 months ago | 509763 |
| 10. | Taylor Frigon Capital Management LLC | 5 months ago | 437961 |
| 11. | Geode Capital Management, LLC | 5 months ago | 358829 |
| 12. | The Informed Momentum Company (formerly EAM Investors) | 5 months ago | 246435 |
| 13. | Huntleigh Advisors Inc | 5 months ago | 236398 |
| 14. | Renaissance Technologies Corp | 5 months ago | 220395 |
| 15. | Susquehanna International Group, LLP | 5 months ago | 201651 |
| 16. | Kingsview Wealth Management, LLC | 5 months ago | 188193 |
| 17. | Jane Street Group LLC | 5 months ago | 168238 |
| 18. | Caption Management, LLC | 5 months ago | 160407 |
| 19. | Perceptive Advisors LLC | 8 months ago | 150000 |
| 20. | 683 Capital Management LLC | 5 months ago | 124506 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...